NAK is an IκB kinase-activating kinase

被引:321
作者
Tojima, Y
Fujimoto, A
Delhase, M
Chen, Y
Hatakeyama, S
Nakayama, K
Kaneko, Y
Nimura, Y
Motoyama, N
Ikeda, K
Karin, M
Nakanishi, M [1 ]
机构
[1] Natl Inst Longev Sci, Dept Geriatr Res, Aichi 4748522, Japan
[2] Nagoya Univ, Sch Med, Dept Surg, Showa Ku, Nagoya, Aichi 4668550, Japan
[3] Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA
[4] Kyusyu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka 8128582, Japan
[5] Japan Sci & Technol Corp, CREST, Higashi Ku, Fukuoka 8128582, Japan
[6] Nagoya City Univ, Sch Med, Dept Biochem, Mizuho Ku, Nagoya, Aichi 4678601, Japan
关键词
D O I
10.1038/35008109
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Phosphorylation of I kappa B by the I kappa B kinase (IKK) complex is a critical step leading to IkB degradation and activation of transcription factor NF-kappa B-1. The IKK complex contains two catalytic subunits, IKK alpha and IKK beta, the latter being indispensable for NF-kappa B activation by pro-inflammatory cytokines(2-7). Although IKK is activated by phosphorylation of the IKK beta activation loop(8), the physiological IKK kinases that mediate responses to extracellular stimuli remain obscure(1,9). Here we describe an IKK-related kinase, named NAK (NF-kappa B-activating kinase), that can activate IKK through direct phosphorylation. NAK induces I kappa B degradation and NF-kappa B activity through IKKb. Endogenous NAK is activated by phorbol ester tumour promoters and growth factors, whereas catalytically inactive NAK specifically inhibits activation of NF-kappa B by protein kinase C-epsilon (PKC epsilon). Thus, NAK is an IKK kinase that may mediate IKK and NF-kappa B activation in response to growth factors that stimulate PKC epsilon activity.
引用
收藏
页码:778 / 782
页数:6
相关论文
共 30 条
[1]   NF-kappa B: Ten years after [J].
Baeuerle, PA ;
Baltimore, D .
CELL, 1996, 87 (01) :13-20
[2]   The NF-kappa B and I kappa B proteins: New discoveries and insights [J].
Baldwin, AS .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :649-683
[3]   Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases [J].
Barnes, PJ ;
Larin, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) :1066-1071
[4]  
BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809
[5]   CENTRAL OF I-KAPPA-B-ALPHA PROTEOLYSIS BY SITE-SPECIFIC, SIGNAL-INDUCED PHOSPHORYLATION [J].
BROWN, K ;
GERSTBERGER, S ;
CARLSON, L ;
FRANZOSO, G ;
SIEBENLIST, U .
SCIENCE, 1995, 267 (5203) :1485-1488
[6]   Positive and negative regulation of IκB kinase activity through IKKβ subunit phosphorylation [J].
Delhase, M ;
Hayakawa, M ;
Chen, Y ;
Karin, M .
SCIENCE, 1999, 284 (5412) :309-313
[7]  
DiDonato J, 1996, MOL CELL BIOL, V16, P1295
[8]   A cytokine-responsive I kappa B kinase that activates the transcription factor NF-kappa B [J].
DiDonato, JA ;
Hayakawa, M ;
Rothwarf, DM ;
Zandi, E ;
Karin, M .
NATURE, 1997, 388 (6642) :548-554
[9]   A selective ε-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death [J].
Gray, MO ;
Karliner, JS ;
Mochly-Rosen, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (49) :30945-30951
[10]   Ubiquitin-dependent degradation of IκBα is mediated by a ubiquitin ligase Skp1/Cul 1/F-box protein FWD1 [J].
Hatakeyama, S ;
Kitagawa, M ;
Nakayama, K ;
Shirane, M ;
Matsumoto, M ;
Hattori, K ;
Higashi, H ;
Nakano, H ;
Okumura, K ;
Onoé, K ;
Good, RA ;
Nakayama, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (07) :3859-3863